Results 11 to 20 of about 449,138 (190)

Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: An Italian Sample

open access: yesFrontiers in Psychology, 2022
Background and AimsRecent studies suggest cognitive, emotional, and behavioral impairments occur in patients after SARS-CoV-2 infection. However, studies are limited to case reports or case series and, to our knowledge, few of them have control groups ...
Veronica Cian   +9 more
doaj   +1 more source

Statin usage, vascular diagnosis and vascular risk factors in Parkinson's disease [PDF]

open access: yes, 2017
Background and aims: Vascular disease is a common comorbidity in Parkinson’s disease patients. Statins are potentially neuroprotective for Parkinson’s disease through non-vascular mechanisms.
Cheng, Kelvin K.W.   +3 more
core   +1 more source

Identifying Parkinson’s Patients: A Functional Gradient Boosting Approach [PDF]

open access: yes, 2017
Parkinson’s, a progressive neural disorder, is difficult to identify due to the hidden nature of the symptoms associated. We present a machine learning approach that uses a definite set of features obtained from the Parkinson’s Progression Markers ...
Dhami, D. S.   +3 more
core   +2 more sources

Targeting Aggrephagy for the Treatment of Alzheimer’s Disease

open access: yesCells, 2020
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in older individuals with specific neuropsychiatric symptoms. It is a proteinopathy, pathologically characterized by the presence of misfolded protein (Aβ and Tau ...
Sandeep Malampati   +14 more
doaj   +1 more source

Clinical Characteristics of Involuntary Movement in Hospitalized Patients [PDF]

open access: yesJournal of Movement Disorders, 2019
Objective Neurological symptoms in hospitalized patients are not rare, and neurological consultation for movement disorders is especially important in evaluating or managing those with various movement disorders.
Kyum-Yil Kwon   +3 more
doaj   +1 more source

Protective potential of glucagon like peptide 2 (GLP-2) against the neurodegeneration [PDF]

open access: yes, 2019
Neurodegeneration consists in loss of neuron specific types, pattern and distribution, leading to progressive dysfunctions of the central nervous system.
Amato, Antonella, Mulè, Flavia
core   +1 more source

Deep learning algorithm reveals two prognostic subtypes in patients with gliomas

open access: yesBMC Bioinformatics, 2022
Background Gliomas are highly complex and heterogeneous tumors, rendering prognosis prediction challenging. The advent of deep learning algorithms and the accessibility of multi-omic data represent a new approach for the identification of survival ...
Jing Tian   +10 more
doaj   +1 more source

Mild Cognitive Impairment in Parkinson's Disease - What Is It? [PDF]

open access: yes, 2018
PURPOSE OF REVIEW: Mild cognitive impairment is a common feature of Parkinson’s disease, even at the earliest disease stages, but there is variation in the nature and severity of cognitive involvement and in the risk of conversion to Parkinson’s disease ...
Costantini, A, Schrag, A, Weil, RS
core   +1 more source

Quality of life in Parkinson’s disease: Italian validation of the Parkinson’s Disease Questionnaire (PDQ-39-IT) [PDF]

open access: yes, 2018
Translation and cross-cultural adaptation of the 39-item Parkinson’s Disease Questionnaire (PDQ-39) to the Italian culture was performed by Oxford University Innovation in 2008, but this version has never been validated.
Berardi, Anna   +8 more
core   +1 more source

Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis [PDF]

open access: yes, 2012
Objective To assess the effectiveness of physiotherapy compared with no intervention in patients with Parkinson’s disease. Design Systematic review and meta-analysis of randomised controlled trials.
Clarke, Carl E.   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy